Health Products

Dimension Creatinine Flex Reagent Cartridge (2016-06-09)

· Published by Health Canada · Official notice

Details

Alert type: Medical Device Recall
Category: Medical Device
Issue: Medical Devices
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type III
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberCompaniesBrand nameModel or catalog number
All lots
Manufacturer
Siemens Healthcare Diagnostics Inc.
500 GBC DRIVE, MAILSTOP 514, P.O. BOX 6101
Newark
19714-6101
Delaware
UNITED STATES
B. Dimension Clinical Chemistry System Creatinine (Cre2) Flex Reagent Cartridge10872079
All lots
Manufacturer
Siemens Healthcare Diagnostics Inc.
500 GBC DRIVE, MAILSTOP 514, P.O. BOX 6101
Newark
19714-6101
Delaware
UNITED STATES
A. Dimension Vista System Creatinine (Cre2) Flex Reagent Cartridge10872082

Introduction

Affected Products
  1. Dimension Vista System Creatinine (Cre2) Flex Reagent Cartridge
  2. Dimension Clinical Chemistry System Creatinine (Cre2) Flex Reagent Cartridge

Reason

Siemens Healthcare Diagnostics has confirmed that Dimension Creatinine (CRE2) Assay and Dimension Vista Creatinine (CRE2) Assay exhibits a negative bias at the low end of the urine analytical measurement range (AMR). The limit of quantitation (LOQ) claim (5 mg/dL [442 umol/L]) for urine samples is not met. Siemens is actively investigating the root cause of the issue and is working to implement a solution. This issue also affects all future lots of CRE2 until a solution is implemented. The serum/plasma CRE2 AMR is not affected by this issue.
Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime